IE 11 is not supported. For an optimal experience visit our site on another browser.

Exact Sciences Corporation (EXAS) President and Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell

ADVISORY, March 25, 2011 (GLOBE NEWSWIRE) --
/ Source: GlobeNewswire

ADVISORY, March 25, 2011 (GLOBE NEWSWIRE) --

What:

Exact Sciences Corporation (EXAS) will visit the NASDAQ MarketSite in New York City's Times Square.

In honor of the occasion, Kevin T. Conroy, President and Chief Executive Officer of Exact Sciences Corporation (EXAS), will preside over the NASDAQ Closing Bell.

Where:

NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Monday, March 28th, 2011 at 3:50 p.m. - 4:00 p.m. ET   

Contacts:

Cara Tucker
Exact Sciences
Manager Corporate Communications
(608) 284-5735
ctucker@exactsciences.com

NASDAQ MarketSite:

Robert Madden
(646) 441-5045
Robert.Madden@NASDAQOMX.com

Feed Information:

The Closing Bell is available from 3:50 p.m. to 4:05 p.m. on AMC-3/C-3 (ul 5985V; dl 3760H). The feed can also be found on Ascent fiber 1623. If you have any questions, please contact Robert Madden at (646) 441-5045.

Radio Feed:

An audio transmission of the Closing Bell is also available from 3:50 p.m. to 4:05 p.m. on uplink IA6 C band/transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.

Facebook and Twitter:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page at:

For news tweets, please visit our Twitter page at:

Webcast:

A live webcast of the NASDAQ Closing Bell will be available at:

Photos:

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Exact Sciences Corporation (EXAS):

Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please visit the company's website at .

About NASDAQ OMX:

The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with approximately 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit . *Please follow NASDAQ OMX on Facebook () and Twitter ().

NDAQA